Top Vaccines companies in Switzerland by Shareholders' Equity
Switzerland
# |
Name |
Shareholders' Equity |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 7.28 B
|
Dec. 31, 2023 | USD 48.28 | 3.35% |
|
Switzerland |
|
| 2 |
USD 495.68 M
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
| 3 |
USD 420.78 M
|
Dec. 31, 2023 | USD 26.45 | -1.05% |
|
Switzerland |
|
| 4 |
USD 209.55 M
|
Dec. 31, 2023 | USD 4.99 | 1.08% |
|
Switzerland |
|
| 5 |
USD 190.80 M
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
| 6 |
USD -11.88 M
|
Dec. 31, 2023 | USD 45.08 | 2.29% |
|
Switzerland |
|
| 7 |
USD -148.25 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
Frequently Asked Questions
-
Which Vaccines company in Switzerland has the highest Shareholders' Equity ?
The Vaccines company in Switzerland with the highest Shareholders' Equity is Sandoz Group AG (Swiss Stock Exchange: SDZ.SW) at USD 7.28 B.
-
Which Vaccines company in Switzerland has the lowest Shareholders' Equity ?
The Vaccines company in Switzerland with the lowest Shareholders' Equity is ADC Therapeutics SA (NYSE: ADCT) at USD -148.25 M.
-
What are the top 10 Vaccines companies in Switzerland by Shareholders' Equity ?
The top 10 Vaccines companies in Switzerland by Shareholders' Equity are Sandoz Group AG, MoonLake Immunotherapeutics, PolyPeptide Group AG, Molecular Partners AG, AC Immune SA, Basilea Pharmaceutica AG and ADC Therapeutics SA.
-
What are the bottom 10 Vaccines companies in Switzerland by Shareholders' Equity ?
The bottom 10 Vaccines companies in Switzerland by Shareholders' Equity are ADC Therapeutics SA, Basilea Pharmaceutica AG, AC Immune SA, Molecular Partners AG, PolyPeptide Group AG, MoonLake Immunotherapeutics and Sandoz Group AG.
